Home > Products > Ang2 & VEGFA
> Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (VHH-IgG)
Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (VHH-IgG) (CAT#: BSSG-358)
Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-VEGFA antibody variable domain are respectively connected to the N terminus of the anti-Ang2 IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb is capable of inhibiting two proangiogenics fators and a combined blockade of them has a greater inhibitory efficacy compared with inhibition of either factor alone. It is designed for the research of Colorectal cancer (CRC); Solid tumors; Wet AMD (Age-related macular degeneration); Diabetic macular edema therapy.
There are currently no customer reviews or questions for Recombinant Anti-Ang2 x Anti-VEGFA Bispecific Antibody (VHH-IgG) (BSSG-358). Click the button below to contact us or submit your feedback about this product.